11/18
08:09 am
zura
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
11/14
04:30 pm
zura
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
High
Report
Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis
11/11
10:22 am
zura
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
11/11
08:10 am
zura
Zura Bio Limited (NASDAQ: ZURA) had its price target lowered by analysts at Chardan Capital from $14.00 to $12.00. They now have a "buy" rating on the stock.
Medium
Report
Zura Bio Limited (NASDAQ: ZURA) had its price target lowered by analysts at Chardan Capital from $14.00 to $12.00. They now have a "buy" rating on the stock.
11/7
06:30 am
zura
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
Medium
Report
Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
11/5
08:19 am
zura
Zura Bio Limited (NASDAQ: ZURA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Medium
Report
Zura Bio Limited (NASDAQ: ZURA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
11/4
08:19 am
zura
Zura Bio Limited (NASDAQ: ZURA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
Medium
Report
Zura Bio Limited (NASDAQ: ZURA) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $15.00 price target on the stock.
10/30
06:30 am
zura
Zura Bio to Participate in Two Upcoming Investor Conferences in November
Low
Report
Zura Bio to Participate in Two Upcoming Investor Conferences in November
10/21
08:07 am
zura
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Low
Report
Zura Bio Limited (NASDAQ: ZURA) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
10/18
08:33 am
zura
Zura Bio Limited (NASDAQ: ZURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Zura Bio Limited (NASDAQ: ZURA) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
9/19
01:14 pm
zura
Zura Bio Limited (NASDAQ: ZURA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $26.00 price target on the stock.
Low
Report
Zura Bio Limited (NASDAQ: ZURA) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $26.00 price target on the stock.
9/5
08:06 am
zura
Zura Bio Limited (NASDAQ: ZURA) is now covered by analysts at HC Wainwright. They set a "neutral" rating and a $5.00 price target on the stock.
Medium
Report
Zura Bio Limited (NASDAQ: ZURA) is now covered by analysts at HC Wainwright. They set a "neutral" rating and a $5.00 price target on the stock.
9/3
06:00 am
zura
Zura Bio to Present at Three Upcoming Investor Conferences in September
Low
Report
Zura Bio to Present at Three Upcoming Investor Conferences in September